UNSPSC 85818729: Transfusion of nonautologous red blood cells into central artery, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to transfusion of nonautologous red blood cells into central artery, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 30263N1

UNSPSC 85818729 Transfusion of nonautologous red blood cells into central artery, percutaneous approach is a Commodity code that shows minimal alignment between its nominal clinical scope and recent state and local procurement activity. The code's technical title describes a specific blood transfusion procedure, yet the recent opportunities posted under this code do not reflect procurement of transfusion services or related blood products. Instead, the tagged solicitations cover occupational medical surveillance, disability medical evaluations, Centers of Excellence surgical networks, pharmacy benefit management, and temporary health professional staffing—none of which involve transfusion administration or blood bank services.

Recent activity includes the Washington State Department of Transportation soliciting occupational medical surveillance services for ferry workers (RFP20260825, due October 9, 2026); the City of Phoenix Retirement Office requesting independent medical evaluation services for disability pension determinations (RTMRFP26001, due October 16, 2026 at 2:00 p.m.); and the County of Santa Clara Health System establishing a qualified vendor pool for temporary ancillary clinical staffing across multiple specialties, excluding nursing and physician services (RFSQHHSFY270052, due October 7, 2026). The issuing bodies are predominantly state health and transportation departments, counties, and municipal retirement systems. The geographic spread includes Washington State, Arizona, California, and Texas. This code carries little decision relevance for firms focused on transfusion medicine, blood bank operations, or perioperative vascular access services.